Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates

Oral Oncol. 2009 Sep;45(9):839. doi: 10.1016/j.oraloncology.2008.11.010. Epub 2009 Jan 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Density Conservation Agents / adverse effects
  • Collagen Type I / blood*
  • Humans
  • Jaw Diseases / blood*
  • Jaw Diseases / chemically induced
  • Jaw Diseases / pathology*
  • Osteonecrosis / blood*
  • Osteonecrosis / chemically induced
  • Osteonecrosis / pathology*
  • Peptides / blood*
  • Research Design
  • Risk Assessment / methods

Substances

  • Bone Density Conservation Agents
  • Collagen Type I
  • Peptides
  • collagen type I trimeric cross-linked peptide